By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
PHARMA JOBS POSTPHARMA JOBS POSTPHARMA JOBS POST
  • HOME
  • FRESHERS
  • LOCATIONS
  • ABOUT US
  • CONTACT
  • DISCLAIMER
Notification
PHARMA JOBS POSTPHARMA JOBS POST
  • HOME
  • FRESHERS
  • LOCATIONS
  • ABOUT US
  • CONTACT
  • DISCLAIMER
Have an existing account? Sign In
Follow US
PHARMA JOBS POST © 2024 All Rights Reserved.
WhatsApp Group Join Now
Telegram Group Join Now
- Advertisement -
Ad imageAd image
Ad imageAd image
PHARMA JOBS POST > Pharma News > FDA Announces Expanded Use of Unannounced Inspections at Foreign Manufacturing Facilities
Pharma News

FDA Announces Expanded Use of Unannounced Inspections at Foreign Manufacturing Facilities

Newspress
Last updated: May 24, 2025 3:58 am
Newspress 1 month ago 314 Views
Share
SHARE

The U.S. Food and Drug Administration announced its intent to expand the use of unannounced inspections at foreign manufacturing facilities that produce foods, essential medicines, and other medical products intended for American consumers and patients. This change builds upon the agency’s Office of Inspection and Investigations Foreign Unannounced Inspection Pilot program in India and China and aims to ensure that foreign companies will receive the same level of regulatory oversight and scrutiny as domestic companies.  

“For too long, foreign companies have enjoyed a double standard—given advanced notice before facility inspections, while American manufacturers are held to rigorous standards with no such warning. That ends today. This is a key step for the FDA as part of a broader strategy to get foreign inspections back on track,” said FDA Commissioner Martin A. Makary, M.D, M.P.H.  

In addition, the FDA will evaluate the agency’s policies and practices for improvements to the foreign inspection program to ensure that the FDA is the gold standard for regulatory oversight. These changes will include clarifying policies for FDA investigators to refuse travel accommodations from regulated industry including lodging and transportation arrangements (taxi, limousine, and for-hire vehicle transit), to maintain the integrity of the oversight process.

The FDA conducts approximately 12,000 domestic inspections and 3,000 foreign inspections each year in more than 90 countries. While U.S. manufacturers undergo frequent, unannounced inspections, foreign firms have often had weeks to prepare, undermining the integrity of the oversight process. Despite the advanced warning that foreign firms receive, the FDA still found serious deficiencies more than twice as often than during domestic inspections.  

Only in specific programs and cases are the FDA’s domestic inspections pre-announced to assure that appropriate records and personnel will be available during the inspection. But regulated companies do not have the authority to negotiate the day or time of the inspection— nor should foreign companies have the capability to do so either. 

With this shift, the FDA is further ensuring that every product entering the U.S. is safe, legitimate, and honestly made. Unannounced inspections will also help expose bad actors—those who falsify records or conceal violations—before they can put American lives at risk. The FDA is authorized to take regulatory action against any firm that seeks to delay, deny, or limit an inspection, or refuses to permit entry for an unannounced drug or device inspection.

“The FDA’s rigorous, science-based global inspections of manufacturing facilities ensure that the food and drug products that enter the U.S. marketplace, and the homes of American consumers, are safe, trusted, and accessible,” said FDA Assistant Commissioner for Inspections and Investigations Michael Rogers. “These inspections provide real-time evidence and insights that are essential for making fact-based regulatory decisions to protect public health.”

The FDA’s global inspections generate real-time intelligence that strengthens enforcement and keeps American families safe. Every inspection goes through a classification assignment process to enable an appropriate regulatory response. Even inspections that yield a “No Action Indicated” provide important regulatory intelligence that strengthens the safety net for American consumers.   

This expanded approach marks a new era in FDA enforcement—stronger, smarter, and unapologetically in support of the public health and safety of Americans. 

WhatsApp Group Join Now
Telegram Group Join Now
- Advertisement -
DEFINE ACADEMY DRUG REGULATORY AFFAIRSDEFINE ACADEMY DRUG REGULATORY AFFAIRS
TAGGED: American consumer, FDA Announcement, Foreign Manufacturing Facilities, pharma news, Unannounced inspection
Share This Article
Facebook Twitter LinkedIn Email Print
Previous Article FDC recalls over 60,000 bottles of ophthalmic solution in US
Next Article Expand Your Career in FDC – Multiple Openings in Quality Control, QualityAssurance & Production (BFS, Formulation)

RECENT POSTS

  • Gland Pharma Apprenticeship Program 2025: Production & Packing Jobs for Freshers
  • Sun Pharma Walk-In Drive 2025: Female Apprentices Wanted in Production – Halol, June 27
  • 🧪 Navamedic to Acquire dne pharma Business for Up to NOK 225 million: A Bold Play in Specialty Pharma
  • 🌟 FDA Greenlights Gilead’s Biannual Injection for HIV Prevention
  • Alvotech and Dr. Reddy’s Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab)
  • Glenmark Pharmaceuticals Launches TEVIMBRA® in India: Expanding Access to
    Innovative Immuno-Oncology Treatment for Non-Small Cell Lung Cancer and Esophageal Squamous Cell Carcinoma
  • Sanofi and Regeneron’s Dupixent Receives FDA Approval for Bullous Pemphigoid
  • Pharma Business Development Careers – Executive/Sr. Executive Roles (LATAM & South East Asia) | Bharat Parenterals Hiring
  • Walk-In Interviews on June 24, 2025 (Tuesday) at Sundyota Numandis (Ahmedabad) – OSD Formulation Jobs
  • FDA Launches Agency-Wide AI Tool to Optimize Performance for the American People
  • MSN Labs Hiring for FAR&D | Walk-In Interview on 27th June 2025
  • Walk-In Interview at Ipca Labs, Silvassa – Hiring for Production, QA, QC, Engineering & More (29th June 2025)
  • Research Associate (Analytical Research) Job at Wockhardt – Apply Now!
JOIN WHATSAPP CHANNEL

Recent Jobs

  • Meril Life Sciences Pvt. Ltd.

    Freshers Apply Now! Meril Life Sciences Offering Production Jobs with ₹1.8–2.0 LPA CTC

    • Chala, Vapi
    • Meril Life Sciences Pvt. Ltd.
  • Chiron Behring Vaccines Pvt. Ltd.

    Walk-In Drive for Freshers at Chiron Behring – Bharat Biotech Group | June 29, Ahmedabad

    • Navrangpura, Ahmedabad
    • Chiron Behring Vaccines Pvt. Ltd.
  • Access Healthcare

    Access Healthcare Hiring Certified Medical Coding Freshers – Walk-In Interview (June 25–28, 2025)

    • Chennai
    • Access Healthcare
  • USV Biologics

    USV Biologics is Hiring Freshers and Experienced Candidates in Biotech R&D – Apply Now!

    • Govandi East, Mumbai, Maharashtra
    • USV Biologics
  • Aurigene Pharmaceutical Services Ltd

    Walk-In Interviews for Process R&D & Engineering Roles at Aurigene | 28th June 2025 | Hyderabad

    • Hyderabad, Telangana
    • Aurigene Pharmaceutical Services Ltd
  • Vsix Analytical Labs Pvt. Ltd.

    Vsix Analytical Labs Pvt. Ltd. – Walk-In Drive for M.Sc Freshers & Experienced Candidates | 27th June 2025

    • BANGALORE, Karnataka
    • Vsix Analytical Labs Pvt. Ltd.
  • Accenture

    Freshers Apply Now – Accenture Pharmacovigilance Job for B.Pharm Graduates

    • Chennai, Tamil Nadu, India
    • Accenture
  • Fortrea

    Fortrea is Hiring in Bangalore: Assistant Clinical Administrator | Full-Time | 0–1 Year Exp

    • Bengaluru, Karnataka, India
    • Fortrea
  • Johnson & Johnson

    Johnson & Johnson Hiring Freshers: Medical Science Liaison Role in Kolkata & Bangalore

    • Kolkata & Bangalore
    • Johnson & Johnson
  • Eris Lifesciences Limited

    Career Opportunities at Eris Lifesciences – Multiple Openings in QC, Warehouse & Soft Gel

    • North Guwahati, Assam
    • Eris Lifesciences Limited
  • Cadila Pharmaceuticals Limited

    Cadila Pharmaceuticals is Looking for Biotech QC Talent – 0 to 3 Years Experience

    • Dholka, Ahmedabad
    • Cadila Pharmaceuticals Limited
  • Panacea Biotec

    Panacea Biotec Walk-In Interview on June 21, 2025 – Multiple Openings in Vaccine & Oncology Plants

    • Sandholi, Baddi
    • Panacea Biotec

Tags

Ahmedabad (65) ahmedabad pharma jobs (189) ahmedabad pharma vacancy (165) ahmedabad pharma walk in interview (89) Baddi Pharma Vacancy (59) Bangalore pharma company jobs (41) Bangalore pharma jobs (31) FRESHERS (181) freshers jobs in pharma industry (50) freshers pharmacy jobs (46) Hiring (119) Hiring jobs (487) Hyderabad (57) hyderabad pharma company jobs (184) hyderabad pharma jobs (94) hyderabad pharma jobs freshers (42) hyderabad pharma vacancies (111) hyd pharma jobs (31) indore pharma company vacancy (27) job alert (409) job Opportunity (246) Job search (487) job Vaccancy (467) Mumbai Pharma company jobs (34) Pharmacovigilance Jobs vacancy (38) Pharma jobs (104) Pharma jobs at Baddi (36) pharma jobs in hyderabad (84) pharma news (39) Pharma QA Jobs (35) pharma qa vacancy (28) pharma vacancy in ahmedabad (30) pharma walk in interview (44) Production (58) Production Department (73) QA (53) QC (77) QC Department (45) Quality Control (QC) (32) Regulatory Affairs (55) Regulatory Affairs Jobs Vacancy (63) Vadodara (33) Vadodara Pharma Job Vacancy (53) Walk In Drive (125) Walk In Interview (180)
PHARMA JOBS POSTPHARMA JOBS POST
Follow US
PHARMA JOBS POST © 2024 All Rights Reserved.
JOIN OUR WHATSAPP GROUP
JOIN OUR TELEGRAM GROUP
Welcome Back!

Sign in to your account

Lost your password?